Prelude Therapeutics CEO Krishna Vaddi's 2022 pay falls 53% to $3.3M
Prelude Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Prelude Therapeutics reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Prelude Therapeutics received on average a compensation package of $2.6M, a 31% decrease compared to previous year.
Average pay of disclosed executives at Prelude Therapeutics
Krishna Vaddi, Chief Executive Officer, received $3.3M in total, which decreased by 53% compared to 2021. 76% of Vaddi's compensation, or $2.5M, was in option awards. Vaddi also received $238K in non-equity incentive plan, $558K in salary, as well as $9.2K in other compensation.
Jane Huang, Chief Medical Officer, received a compensation package of $2.9M. 56% of the compensation package, or $1.6M, was in option awards.
Peggy Scherle, Chief Scientific Officer, earned $1.6M in 2022, a 38% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.